bluebird bio Inc – Strategy, SWOT and Corporate Finance Report
- Pages: 53
- Published: May 2019
- Report Code: MLPH137067FSA
bluebird bio Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Bluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti D for the treatment of cerebral adrenoleukodystrophy (CALD); LentiGlobin for the treatment of transfusion-dependent beta thalassemia and sickle cell disease, besides compounds under development for the treatment of various cancers. The company has collaboration with pharmaceutical companies to discover, develop and commercialize gene therapy products. bluebird bio is headquartered in Cambridge, Massachusetts, the US.
Scope
Detailed information on bluebird bio Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting bluebird bio Inc in the form of a SWOT analysis
An in-depth view of the business model of bluebird bio Inc including a breakdown and examination of key business segments
News about bluebird bio Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of bluebird bio Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess bluebird bio Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on bluebird bio Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Global Blood Therapeutics Inc
Acceleron Pharma Inc
Bellicum Pharmaceuticals Inc
Adaptimmune LLC
Intellia Therapeutics Inc
GlycoMimetics Inc
Juno Therapeutics Inc
Sangamo Therapeutics Inc
ApoPharma Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.